Immunorel 5gm Solution for Infusion contains Human Gamma Globulin (5% w/v), a sterile, purified preparation of immunoglobulin G (IgG) derived from pooled human plasma. It is indicated for the treatment and prevention of various immunodeficiency disorders, including primary humoral immunodeficiency, secondary immunodeficiency states, and certain autoimmune conditions. Immunorel provides passive immunity by supplying a broad spectrum of antibodies that enhance the patient’s immune response against bacterial and viral infections. The solution is administered intravenously under strict aseptic conditions, with dosage individualized based on the patient’s weight, clinical condition, and serum IgG levels. Prior to infusion, patients should be evaluated for potential hypersensitivity to human plasma proteins. Adverse reactions may include mild infusion-related symptoms such as headache, chills, fever, and nausea; severe hypersensitivity reactions are rare but require immediate medical intervention. Immunorel is contraindicated in patients with known anaphylactic or severe systemic reactions to human immunoglobulin or any component of the formulation. Careful monitoring during and after infusion is recommended to detect any adverse effects promptly. This product should be stored according to manufacturer instructions to maintain stability and efficacy. Immunorel is a vital therapeutic option in managing immunodeficiency and enhancing immune protection in vulnerable patient populations.